AULSF (Austar Lifesciences) Inventory Turnover: 2.83 (As of Dec. 2025)

What is Austar Lifesciences Inventory Turnover?

Austar Lifesciences AULSF 48 Inventory Turnover is 2.83 as of Dec. 2025. GuruFocus rates AULSF with a GF Score™ of 48/100 and a GF Value™ of $0.08 (Possible Value Trap). The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Austar Lifesciences's Cost of Goods Sold for the six months ended in Dec. 2025 was $101.5 Mil. Austar Lifesciences's Average Total Inventories for the quarter that ended in Dec. 2025 was $35.8 Mil. Austar Lifesciences's Inventory Turnover for the quarter that ended in Dec. 2025 was 2.83.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Austar Lifesciences's Days Inventory for the six months ended in Dec. 2025 was 64.40.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Austar Lifesciences's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.29.

Austar Lifesciences (OTCPK:AULSF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Austar Lifesciences's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	35.805	/	101.465	*	365 / 2
	=	64.40

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Austar Lifesciences's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	35.805	/	123.348
	=	0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Austar Lifesciences Inventory Turnover Related Terms

Austar Lifesciences Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Austar Lifesciences's Inventory Turnover can be seen below:

Austar Lifesciences Inventory Turnover Chart

Austar Lifesciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

4.90

3.92

4.46

4.93

4.85

Austar Lifesciences Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															2.43	2.23	2.62	2.25	2.83

48GF Score

Austar Lifesciences Ltd AULSF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Austar Lifesciences Inventory Turnover Calculation

Austar Lifesciences's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	175.687	/ (	(32.748	+	39.705)	/	2 )
=	175.687	/	36.2265
=	4.85

Austar Lifesciences's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	101.465	/ (	(31.905	+	39.705)	/	2 )
=	101.465	/	35.805
=	2.83

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 2.83 mean?

Austar Lifesciences (AULSF) has a Inventory Turnover of 2.83 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Austar Lifesciences and its competitors.

Is Austar Lifesciences' Inventory Turnover too high?

Austar Lifesciences' current Inventory Turnover is 2.83. Overall, Austar Lifesciences has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Austar Lifesciences' Inventory Turnover compare to ABT and SYK?

Austar Lifesciences' Inventory Turnover of 2.83 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Devices & Instruments company?

A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Austar Lifesciences and its competitors. Austar Lifesciences's current Inventory Turnover is 2.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Austar Lifesciences stock overvalued right now?

Based on GuruFocus' analysis, Austar Lifesciences (AULSF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.02 — trading 75% below its estimated fair value. The current Inventory Turnover is 2.83. Austar Lifesciences' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Austar Lifesciences (AULSF), the current Inventory Turnover is 2.83 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Austar Lifesciences (AULSF) Overvalued in 2026?

Based on GuruFocus' analysis, Austar Lifesciences stock appears to be undervalued. The current stock price of $0.02 is trading 75% below its estimated GF Value™ of $0.08. GuruFocus considers Austar Lifesciences to be Possible Value Trap.

Key valuation signals for AULSF:

Inventory Turnover: 2.83
GF Value™: $0.08 vs. price of $0.02 (75% below fair value)
GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the AULSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Austar Lifesciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies HKSE:02170 HKSE:02297 HKSE:02216 HKSE:01612 HKSE:02500 HKSE:02393 HKSE:02407 HKSE:06922 HKSE:01696 HKSE:02160 ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges 06118:Hong Kong

Address No.1018 Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website https://www.austar.com.hk

Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.

48GF Score

Get the complete analysis for AULSF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02

Price

$0.08

GF Value

View AULSF Analysis

See Inventory Turnover data for all stocks →